Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Left Atrial Appendage Closure: As Effective in Men and Women?

Atrial fibrillation is the most prevalent arrhythmia and to prevent its potential complications, we should administer anticoagulants (OACs), either warfarin or the new direct oral anticoagulants (DOACs). 

Cierre de orejuela de aurícula izquierda

Even though these drugs have been shown effective, they still involve the risk of bleeding, especially gastrointestinal bleeding, which in turn leads to numerous hospitalizations.

Left atrial appendage occlusion devices (LAAO) have been shown beneficial, even though in general terms they show similar outcomes to oral anticoagulants (OACs). At present, they are clearly recommended for patients who for whatever reason cannot be treated with OACs. 

There is little evidence looking at these benefits by sex.

This was a meta-analysis of the prospective EVOLUTION study, carried out in Europe in patients receiving the WATCHMAN in a “real world” context. The sample included 408 women and 612 men. 

Primary end point assessed the combination of mortality free survival, severe bleeding, ischemic stroke, TIA and systemic embolism over 2 years. 

Read also: Predictors and Evolution of Permanent Pacemaker After TAVR with Self-Expanding Valves.

Even though women were older (75 ± 9 vs. 73 ± 9 years, p < 0.001), they showed a lower incidence of peripheral vascular disease, hemorrhagic stroke and alcohol abuse. However, CHA2DS2‐VASc‐Score was superior (5 ± 1.5 vs. 4.1 ± 1.5, p < 0.001) and HAS‐BLED Score was comparable, with no difference in the rest of risk factors. 

During procedure, women showed better sealing vs. men (94% vs. 90%, p = 0.033), but presented higher incidence of pericardial effusion (1.2% vs. 0.2%, p = 0.031). Pericardial effusion and cardiac tamponade were rare, and similar between groups. 

After two years, there were no difference between men and women in primary end point (79% vs. 76%, p = 0.24) or survival (85% vs. 82%, p = 0.16).

Conclusion

Even though women undergoing LAAO differ in baseline characteristics, after adjusting for variables they showed similar safety and efficacy, with no significant differences at long term followup between men and women. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Sex‐related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.

Reference: Christina Paitazoglou, et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...